 | Innate Pharma S.A. | |||
| NMS : IPHA || Location: France | ||||
$2.41-0.18 (-6.95%) |
0.02 M | 2.34 - 2.57 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.077 M |
| March 15, 2024 | 0.078 M |
| Feb. 29, 2024 | 0.078 M |
| Feb. 15, 2024 | 0.076 M |
| Jan. 31, 2024 | 0.076 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/30/2019 | 0.32 | 0.20 | -38.12% |
IPHA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 80.842M | Shares Float | 30.661M |
| Short Float | 0.077M | Market Cap | 194.83M |
| Institution ownership | 0.14% | Insider ownership | 0.000% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -0.10 | Forward EPS | 0.45 |